NUC-7738: Clinical Trials

1 trial of NUC-7738, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow NUC-7738: new trials by email Literature Review of NUC-7738 trials Research Report on NUC-7738

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
NUC-7738, Pembrolizumab - Advanced Cancer, Lymphoma
Phase 1 / Phase 2RecruitingNuCana plc1352019-06-172026-01-12

Conditions studied

Lymphoma (1)  ·  Melanoma (1)

Sponsors

NuCana plc (1)

Countries

United Kingdom (1)

NIH funding

2018 (1)